Skip to main content

Table 1 Baseline demographic information

From: Anemia, transfusion, and phlebotomy practices in critically ill patients with prolonged ICU length of stay: a cohort study

Parameter

All patients (n = 155)

Never transfused (n = 59)

Ever transfuseda (n = 71)

P value

Age (years)

62.3 ± 16.3

61.2 ± 18.0

62.9 ± 15.8

0.56

Male (n [%])

98 (63%)

35 (59%)

50 (70%)

0.19

BMIb (kg/m2)

26.6 ± 7.3

26.6 ± 7.1

26.5 ± 7.8

0.95

Surgical (%)

64 (41%)

19 (32%)

33 (46%)

0.10

APACHE II score

23.4 ± 8.0

20.5 ± 8.9

24.4 ± 6.9

0.007

Admission diagnosis (n [%])

   

0.24c

   Respiratory

58 (37%)

26 (44%)

25 (35%)

 

   Cardiovascular

41 (26%)

14 (24%)

20 (28%)

 

   Gastrointestinal

32 (21%)

8 (13%)

19 (27%)

 

   Neurologic

12 (8%)

7 (12%)

4 (6%)

 

   Other

12 (8%)

4 (7%)

3 (4%)

 

Comorbidities (n [%])

    

   CAD

37 (24%)

10 (17%)

19 (27%)

0.18

   CHF

18 (12%)

5 (8%)

9 (13%)

0.44

   CVA

15 (10%)

7 (12%)

6 (8%)

0.52

   DM

31 (20%)

10 (17%)

16 (23%)

0.43

   COPD

38 (25%)

15 (25%)

18 (25%)

0.99

   HTN

41 (26%)

13 (22%)

20 (28%)

0.42

   Cancer

19 (12%)

6 (10%)

11 (15%)

0.37

   ESRD

7 (5%)

1 (2%)

5 (7%)

0.22c

Medications (n [%])

    

   Erythropoietin

24 (15%)

2 (3%)

16 (23%)

0.002

   Iron

39 (25%)

9 (15%)

24 (34%)

0.016

Hemoglobin (g/dl)

    

   Day 0

11.1 ± 2.5

11.8 ± 2.5

10.8 ± 2.5

0.04

   Day 7

9.4 ± 1.4

9.8 ± 1.5

9.2 ± 1.2

0.003

   Day 14

9.0 ± 1.2

9.4 ± 1.3

8.8 ± 1.0

0.002

   Day 21

9.0 ± 1.1

9.4 ± 1.2

8.8 ± 0.9

0.001

  1. aExcludes 25 patients with active bleeding. bBMI unavailable for three bleeding patients and 12 nonbleeding patients (five nontransfused patients and seven transfused patients). cFisher's exact test for small samples of categorical variables. APACHE, Acute Physiology and Chronic Health Evaluation; BMI, body mass index; CAD, coronary artery disease; CHF, coronary heart failure; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular accident; DM, diabetes mellitus; ESRD, end-stage renal disease; HTN, hypertension.